Combined Screening for Gastrointestinal Tumors
NCT06478030 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200000
Last updated 2025-01-28
Summary
All participants are required to complete a questionnaire, a Helicobacter pylori (H. pylori) test, and a fecal immunochemical test (FIT). The questionnaire covers nine aspects: basic information of the participants, symptoms and previous examinations, medical history and surgical history, medication history, smoking history, alcohol consumption history, dietary habits, physical exercise, and family history. After quality control, the data is entered by staff into the Zhejiang Province Cancer Screening Information Platform. Risk assessments are performed based on the data collected and high-risk individuals are recommended for clinical screening. Additionally, tongue image, stool, urine, blood, tongue coating, saliva, gastric juice, and fresh tissue (gastric mucosa tissue and/or intestinal polyp tissue) samples are collected from all participants undergoing clinical screening.
Participants are required to complete at least one passive follow-up annually. Active follow-ups are conducted for those with positive screening results to ensure timely completion of endoscopic examinations. For those who have not undergone endoscopic examinations despite positive screening results, health education is provided, and they are mobilized at least four times within one month to complete endoscopic examinations. For participants diagnosed and treated for precancerous lesions and tumors, diagnostic and treatment data must be collected, and they are encouraged to follow up as per medical advice. Both active and passive follow-up results must be recorded in the screening follow-up information record form and reported to the Zhejiang Province Cancer Screening Information Platform.
This is a government collaboration project. All subjects will also be followed by record linkage to Cancer Register and Population Register.
Conditions
- Gastrointestinal Tumors
Interventions
- DIAGNOSTIC_TEST
-
questionnaire, Helicobacter pylori (H. pylori) test, fecal immunochemical test (FIT)
The questionnaire covers nine aspects: basic information of the participants, symptoms and previous examinations, medical history and surgical history, medication history, smoking history, alcohol consumption history, dietary habits, physical exercise, and family history.
Sponsors & Collaborators
-
Fenghua District People's Hospital, Ningbo City
collaborator UNKNOWN -
Fenghua District Traditional Chinese Medicine Hospital, Ningbo City
collaborator UNKNOWN -
Xikou Hospital in Fenghua District, Ningbo City
collaborator UNKNOWN -
Yongkang Traditional Chinese Medicine Hospital
collaborator UNKNOWN -
Hangzhou Medical College
collaborator OTHER -
Zhejiang Cancer Hospital
lead OTHER
Eligibility
- Min Age
- 40 Years
- Max Age
- 74 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-01
- Primary Completion
- 2027-12-31
- Completion
- 2028-12-31
Countries
- China
Study Locations
More Related Trials
-
Pepsinogen II and Helicobacter Pylori Test in Gastric Cancer
NCT06301464 ·Status: ACTIVE_NOT_RECRUITING
-
Screening for Early Gastric Cancer in Shaanxi Province
NCT05291728 ·Status: RECRUITING
-
Metabonomics Study of Chronic Gastritis and Gastric Carcinoma
NCT04624282 ·Status: UNKNOWN
-
Early Detection and Screening Strategy of Gatric Cancer in Sichuan Province-A Prospective Cohort Study (WCH-GC-SIGES-01)
NCT03597672 ·Status: UNKNOWN
-
Measurement and Analysis of Gas Composition in Digestive Tract
NCT05810805 ·Status: UNKNOWN
-
Establishment and Effectiveness Evaluation of a Training System for Confocal Laser Endomicroscopy
NCT06981819 ·Status: COMPLETED
-
A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies Screening
NCT07032961 ·Status: RECRUITING
-
Screening Strategy for Gastric Cancer Prevention
NCT05387005 ·Status: RECRUITING ·Phase: NA
-
Risk Assessment and Syndrome Evolution Models for Chronic Atrophic Gastritis Malignant Transformation
NCT03261934 ·Status: RECRUITING
-
Blood Tests for Gastritis and Gastric Neoplasms
NCT05883345 ·Status: COMPLETED
-
Syndrome Patterns for Chronic Atrophic Gastritis Malignant Transformation
NCT03314038 ·Status: UNKNOWN
-
Helicobacter Pylori 23S rRNA/gyrA Gene Mutation Detection Kit (Fluorescence PCR Fusion Curve Method)
NCT05410652 ·Status: COMPLETED
-
Diagnosis of Gastric Precancerous Lesions by a Blood Test GastroPanel in Patients With Increased Gastric Cancer Risk
NCT02624271 ·Status: COMPLETED ·Phase: NA
-
Related Factors of Hp Infection in Physical Examination and Community Population in Hunan Province
NCT06399562 ·Status: COMPLETED
-
Gastric Cancer Screening and Alarm Symptoms in Early Gastric Cancer
NCT01659632 ·Status: UNKNOWN
-
An Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter Pylori
NCT06896370 ·Status: RECRUITING
-
Reinfection After Eradication of Helicobacter Pylori Infection
NCT02674802 ·Status: UNKNOWN
-
The Application of Extracellular Vesicle Detection in Gastric Juice Based on Metamaterial Sensing in the Diagnosis of Gastric Cancer and Related Diseases
NCT07332104 ·Status: NOT_YET_RECRUITING
-
Observational Study on GER in Patients With Simple Obesity
NCT07188571 ·Status: COMPLETED
-
Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication
NCT01678027 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Individually Tailored Strategies for the Precision Prevention of Gastric Cancer and Colorectal Cancer in the Community
NCT03793335 ·Status: ENROLLING_BY_INVITATION
-
Atrophic Gastritis Predicts the Risk of Gastric Cancer
NCT06203327 ·Status: RECRUITING
-
Predicting Gastric Neoplasia in Patients with High-risk Endoscopic Features
NCT06853509 ·Status: NOT_YET_RECRUITING
-
Multi-omics Analyses on Etiology and Early Detection of Stomach Cancer Precursor Lesions
NCT06267703 ·Status: ACTIVE_NOT_RECRUITING
-
Medical Consortium for Screening Upper Gastrointestinal Cancers With Magnetically Controlled Capsule Gastroscopy
NCT04032353 ·Status: UNKNOWN ·Phase: NA